Tenofovir disoproxil

Tenofovir disoproxil, sold under the trade name Viread among others, is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. It is available by mouth as a tablet or powder.

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

5,494

Prior Five Years

2,101

Total Citations

Lifetime

93,500

Prior Five Years

16,549

Total Scholars

Lifetime

12,823

Prior Five Years

11,167

Institutional Rankings

Global (Worldwide)

Academic Institutions Lifetime		Academic Institutions Prior Five Years		Non-academic Institutions Lifetime
#1	University of Colorado Anschutz Medical Campus United States	#1	Yonsei University South Korea	#1	Gilead Sciences, Inc. United States
#2	Johns Hopkins University United States	#2	University of Colorado Anschutz Medical Campus United States	#2	Institut National de la Santé et de la Recherche Médicale France
#3	University of Washington United States	#3	University of Ulsan South Korea	#3	Carlos III Health Institute Spain
#4	University of Central Florida United States	#4	Ulsan College South Korea	#4	University Health Network Canada
#5	KU Leuven Belgium	#5	Chinese University of Hong Kong Hong Kong	#5	Chelsea and Westminster Hospital NHS Foundation Trust United Kingdom
#6	Université de Paris France	#6	Edge Hill University United Kingdom	#6	Brigham and Women's Hospital United States
#7	University of Cincinnati United States	#7	Queen Mary University of London United Kingdom	#7	St. Vincent's Hospital Ireland
#8	University of Leipzig Germany	#8	University of Central Florida United States	#8	AbbVie Inc. United States
#9	University of North Carolina at Chapel Hill United States	#9	Université de Paris France	#9	Czech Academy of Sciences Czechia
#10	University of Auckland New Zealand	#10	University of Milan Italy		Show More
	Show More		Show More

National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime

Prior Five Years

Evaluation Period:

Highly Cited Publications

Lifetime